Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, William A. Wood, Anita D’Souza et al.|Blood|2017Cited by 296
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow TransplantationMohamad Mohty, Rafael F. Duarte, Kai Hübel et al.|Bone Marrow Transplantation|2014Cited by 192
Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern eraH. Jean Khoury, Joseph Pidala, Tao Wang et al.|Haematologica|2017Cited by 109
Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity ConditioningOlle Ringdén, Navneet S. Majhail, Ruta Brazauskas et al.|Biology of Blood and Marrow Transplantation|2014Cited by 67
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64